Molecule Details
| InChIKey | VLIFEMCYJRKROE-FQBWVUSXSA-N |
|---|---|
| Compound Name | [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-(4-sulfamoyloxypiperidin-1-yl)sulfonyloxan-2-yl]methyl acetate |
| Canonical SMILES | CC(=O)OC[C@H]1O[C@@H](S(=O)(=O)N2CCC(OS(N)(=O)=O)CC2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.5 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile